Ph.D. Reza Zadno - 09 May 2025 Form 4 Insider Report for PROCEPT BioRobotics Corp (PRCT)

Role: President, CEO, Director
Signature: /s/ Jonathan Stone, Attorney-in-Fact for Reza Zadno, Ph.D.
Issuer symbol: PRCT
Transactions as of: 09 May 2025
Net transactions value: +$100,028
Form type: 4
Filing time: 13 May 2025, 16:59:33 UTC
Previous filing: 19 Mar 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Zadno Reza	President, CEO, Director	C/O PROCEPT BIOROBOTICS CORPORATION, 150 BAYTECH DRIVE, SAN JOSE	/s/ Jonathan Stone, Attorney-in-Fact for Reza Zadno, Ph.D.	13 May 2025	0001632326

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PRCT	Common Stock	Options Exercise	$100,028	+13,759	+7.9%	$7.27	186,829	09 May 2025	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PRCT	Stock Option (Right to Buy)	Options Exercise	$0	-13,759	-8%	$0.000000	158,871	09 May 2025	Common Stock	13,759	$7.27	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Stock option was granted on June 22, 2021 and vests 25% on the six month anniversary of the grant date and the remainder vests on each monthly anniversary over a four year period thereafter, subject continued employment or service to the Issuer through the applicable vesting date.